📊 ULBI Key Takeaways
Is Ultralife Corp. (ULBI) a Good Investment?
Ultralife faces operational losses with -3.1% operating margin and zero revenue growth, indicating fundamental business deterioration despite positive free cash flow. The company cannot service debt from operations (interest coverage -30x) and is destroying shareholder value with negative ROE/ROA, making current fundamentals unsustainable without significant operational improvement.
Why Buy Ultralife Corp. Stock? ULBI Key Strengths
- Positive free cash flow of $7.1M despite operating losses, suggesting underlying cash generation from working capital management or non-cash charges
- Strong liquidity position with 2.83x current ratio and 1.39x quick ratio, enabling near-term obligation fulfillment
- Conservative capital structure with 0.35x debt-to-equity ratio, reducing financial distress risk relative to total liabilities
ULBI Stock Risks: Ultralife Corp. Investment Risks
- Operating losses of -$5.9M on flat $191.2M revenue with negative 3.1% net margin indicate unprofitable core business model
- Negative interest coverage ratio (-30x) shows inability to service $45.5M long-term debt from operations; dependent on asset liquidation or refinancing
- Deteriorating per-share metrics with -$35.00 diluted EPS down 192% YoY, signaling severe shareholder value destruction and potential capital raise dilution
Key Metrics to Watch
- Operating margin trend - must return to positive to demonstrate business viability
- Revenue growth acceleration - 0% YoY growth is unsustainable; needs organic or acquired growth
- Debt reduction pace relative to operating cash flow - company must prioritize deleveraging given negative interest coverage
Ultralife Corp. (ULBI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 3.7% FCF margin may limit capital allocation flexibility. Strong liquidity with a 2.83x current ratio provides a solid financial cushion.
ULBI Profit Margin, ROE & Profitability Analysis
ULBI vs Utilities Sector: How Ultralife Corp. Compares
How Ultralife Corp. compares to Utilities sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Ultralife Corp. Stock Overvalued? ULBI Valuation Analysis 2026
Based on fundamental analysis, Ultralife Corp. has mixed fundamental signals relative to the Utilities sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Ultralife Corp. Balance Sheet: ULBI Debt, Cash & Liquidity
ULBI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Ultralife Corp.'s revenue has grown significantly by 77% over the 5-year period, indicating strong business expansion. The most recent EPS of $38.00 reflects profitable operations.
ULBI Revenue Growth, EPS Growth & YoY Performance
ULBI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $35.7M | $258.0K | $0.02 |
| Q2 2025 | $43.0M | $879.0K | $0.05 |
| Q1 2025 | $41.9M | $1.9M | $0.02 |
| Q3 2024 | $35.7M | $258.0K | $0.02 |
| Q2 2024 | $42.7M | $3.0M | $0.03 |
| Q1 2024 | $31.9M | -$346.0K | $0.03 |
| Q3 2023 | $33.2M | $105.0K | $0.02 |
| Q2 2023 | $32.1M | $344.0K | $0.02 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Ultralife Corp. Dividends, Buybacks & Capital Allocation
ULBI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Ultralife Corp. (CIK: 0000875657)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ULBI
What is the AI rating for ULBI?
Ultralife Corp. (ULBI) has an AI rating of SELL with 78% confidence, based on fundamental analysis of SEC EDGAR filings.
What are ULBI's key strengths?
Claude: Positive free cash flow of $7.1M despite operating losses, suggesting underlying cash generation from working capital management or non-cash charges. Strong liquidity position with 2.83x current ratio and 1.39x quick ratio, enabling near-term obligation fulfillment.
What are the risks of investing in ULBI?
Claude: Operating losses of -$5.9M on flat $191.2M revenue with negative 3.1% net margin indicate unprofitable core business model. Negative interest coverage ratio (-30x) shows inability to service $45.5M long-term debt from operations; dependent on asset liquidation or refinancing.
What is ULBI's revenue and growth?
Ultralife Corp. reported revenue of $191.2M.
Does ULBI pay dividends?
Ultralife Corp. does not currently pay dividends.
Where can I find ULBI SEC filings?
Official SEC filings for Ultralife Corp. (CIK: 0000875657) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ULBI's EPS?
Ultralife Corp. has a diluted EPS of $-35.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ULBI a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Ultralife Corp. has a SELL rating with 78% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ULBI stock overvalued or undervalued?
Valuation metrics for ULBI: ROE of -4.5% (sector avg: 10%), net margin of -3.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ULBI stock in 2026?
Our dual AI analysis gives Ultralife Corp. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ULBI's free cash flow?
Ultralife Corp.'s operating cash flow is $11.0M, with capital expenditures of $3.9M. FCF margin is 3.7%.
How does ULBI compare to other Utilities stocks?
Vs Utilities sector averages: Net margin -3.1% (avg: 12%), ROE -4.5% (avg: 10%), current ratio 2.83 (avg: 0.8).